Bioextrax AB TEMP's next confirmed earnings release is scheduled for November 20, 2026.
| Earnings Date | 11/20/2026 |
As of June 30, 2026, Bioextrax AB TEMP has 40.74M shares outstanding.
| Shares Outstanding | 40.74M |
As of June 30, 2026, Bioextrax AB TEMP maintains a current ratio of 3.53, meaning it holds 3.5x the short-term assets needed to cover near-term liabilities.
| Current Ratio | 3.53 |
| Quick Ratio | 2.95 |
| Interest Coverage | -17,630.00 |
Over the twelve months ended June 30, 2026, Bioextrax AB TEMP posted a negative return on equity (ROE) of -124.01, meaning shareholder capital produced losses rather than profits. Return on assets (ROA) is negative at -107.51, reflecting losses generated across the asset base.
| Return on Equity (ROE) | -124.01 |
| Return on Assets (ROA) | -107.51 |
Over the twelve months ended June 30, 2026, Bioextrax AB TEMP generated 545,000.00 in revenue and converted that into -18.57M in net income, yielding earnings per share of -0.50. EBITDA reached -17.63M, while operating income came in at -18.68M.
| Revenue | 545,000.00 |
| Gross Profit | -514,000.00 |
| Operating Income | -18.68M |
| Pretax Income | -18.57M |
| Net Income | -18.57M |
| EBITDA | -17.63M |
| EBIT | -18.68M |
| Earnings Per Share (EPS) | -0.50 |
These figures are as of June 30, 2026. Total book value stands at 11.98M, with working capital of 6.33M providing operational flexibility.
| Cash & Cash Equivalents | 7.39M |
| Net Debt | -7.39M |
| Equity (Book Value) | 11.98M |
| Book Value Per Share | 0.29 |
| Working Capital | 6.33M |
Bioextrax AB TEMP produced -15.66M in operating cash flow over the twelve months ended June 30, 2026. After subtracting -171,000.00 in capital expenditures, free cash flow totaled -15.83M - equivalent to -0.43 per share.
| Operating Cash Flow | -15.66M |
| Capital Expenditures | -171,000.00 |
| Free Cash Flow | -15.83M |
| FCF Per Share | -0.43 |
Over the twelve months ended June 30, 2026, Bioextrax AB TEMP posted a gross margin of -94.31, reflecting its pricing power and cost economics. The operating margin of -3,427.71 and net profit margin of -3,407.52 provide insight into operational efficiency.
| Gross Margin | -94.31 |
| Operating Margin | -3,427.71 |
| Pretax Margin | -3,407.52 |
| Profit Margin | -3,407.52 |
| EBITDA Margin | -3,234.86 |
Already premium?